EPIVA

Epiva is an immuno-microbiome therapeutics platform. Epiva is the next breakthrough microbiome company from Flagship VentureLabs, the innovation foundry of Flagship Ventures. As of July 12, 2016, Epiva Biosciences, Inc. was acquired by Evelo Biosciences. Epiva Biosciences, Inc. develops immunobiotic therapeutics, a class of primed bacterial interventions designed to restore normo-biosis, the microbiome signature normally found in healthy people. It focuses on treating conditions characterized by inflammation and aberrant immune responses by modulating the systemic microbiome, the host immune-bacteria interface. The company was founded in 2015 and is based in Cambridge, Massachusetts.

#SimilarOrganizations #People #Website #More

EPIVA

Social Links:

Linkedin

Twitter

Facebook

Instagram

Youtube

Industry:

Biopharma Biotechnology Health Care Therapeutics

Founded:

2015-01-01

Address:

Cambridge, Massachusetts, United States

Country:

United States

Website Url:

http://www.epiva.com

Total Employee:

11+

Status:

Active

Email Addresses:

[email protected]

Technology used in webpage:

SPF Amazon ASP.NET IIS ASP.NET 4.0 AWS Global Accelerator IIS 7

Similar Organizations

galenea-logo

Galenea

Galenea is engaged in developing therapeutics for central nervous system diseases.

Current Employees Featured

simba-gill_image

Simba Gill
Simba Gill CEO @ Epiva
CEO

not_available_image

Mark Bodmer
Mark Bodmer Chief Scientific Officer & President of R&D @ Epiva
Chief Scientific Officer & President of R&D
2016-04-01

kareem-reda_image

Kareem Reda
Kareem Reda Vice President Business Development & Strategy @ Epiva
Vice President Business Development & Strategy
2015-08-01

Official Site Inspections

http://www.epiva.com

Host Informations
Whois Informations

Loading ...

More informations about "Epiva" on Search Engine